Drugs / GanMaoKangNing Granules
last change Jul 2019 re-read 2 minutes ago

GanMaoKangNing Granules

Developed for
influenza
Investigated by
Dalian Zhen-Ao Bio-Tech Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02989012 ? → Jul 2019 influenza Dalian Zhen-Ao Bio-Tech Co., Ltd. Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GanMaoKangNing Granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT02989012